Current Practice Patterns and Educational Needs of Rheumatologists Who Manage Patients with Rheumatoid Arthritis.

about

Depression Risk in Patients with Rheumatoid Arthritis in the United Kingdom.Routine Use of Quantitative Disease Activity Measurements among US Rheumatologists: Implications for Treat-to-target Management Strategies in Rheumatoid Arthritis.

P2860

Q33725540-6AA90CB0-F6DF-49D2-ABD3-32E090590301 Q47590574-9D797C59-47E9-4257-A6EE-59951C5ED567

P2860

Current Practice Patterns and Educational Needs of Rheumatologists Who Manage Patients with Rheumatoid Arthritis.

Item

http://www.wikidata.org/entity/Q36942985

description

2014 nî lūn-bûn

@nan

2014年の論文

@ja

2014年論文

@yue

2014年論文

@zh-hant

2014年論文

@zh-hk

2014年論文

@zh-mo

2014年論文

@zh-tw

2014年论文

@wuu

2014年论文

@zh

2014年论文

@zh-cn

name

Current Practice Patterns and ...... nts with Rheumatoid Arthritis.

@en

type

Item

label

Current Practice Patterns and ...... nts with Rheumatoid Arthritis.

@en

prefLabel

Current Practice Patterns and ...... nts with Rheumatoid Arthritis.

@en

P1476

Current Practice Patterns and ...... ents with Rheumatoid Arthritis

@en

P2093

Dale Kummerle

http://www.w3.org/2001/XMLSchema#string

Sheila Kelly

http://www.w3.org/2001/XMLSchema#string

Terry Ann Glauser

http://www.w3.org/2001/XMLSchema#string

P2860

2012 update of the 2008 American College of Rheumatology recommendations for the use of disease-modifying antirheumatic drugs and biologic agents in the treatment of rheumatoid arthritis

EULAR recommendations for the management of rheumatoid arthritis with synthetic and biological disease-modifying antirheumatic drugs: 2013 update

A randomized comparative effectiveness study of oral triple therapy versus etanercept plus methotrexate in early aggressive rheumatoid arthritis: the treatment of Early Aggressive Rheumatoid Arthritis Trial

Physician preference motivates the use of anti-tumor necrosis factor therapy independent of clinical disease activity.

EULAR recommendations for the management of rheumatoid arthritis with synthetic and biological disease-modifying antirheumatic drugs

Initial management of rheumatoid arthritis.

American College of Rheumatology 2008 recommendations for the use of nonbiologic and biologic disease-modifying antirheumatic drugs in rheumatoid arthritis.

Understanding emerging treatment paradigms in rheumatoid arthritis

Prescribing practices in a US cohort of rheumatoid arthritis patients before and after publication of the American College of Rheumatology treatment recommendations.

Efficacy, tolerability and cost effectiveness of disease-modifying antirheumatic drugs and biologic agents in rheumatoid arthritis.

P2888

s40744-014-0004-5

P304

31-44

http://www.w3.org/2001/XMLSchema#string

P31

scholarly article

P356

10.1007/S40744-014-0004-5

http://www.w3.org/2001/XMLSchema#string

P433

http://www.w3.org/2001/XMLSchema#string

P478

http://www.w3.org/2001/XMLSchema#string

P50

Eric M Ruderman

P577

2014-09-26T00:00:00Z

http://www.w3.org/2001/XMLSchema#dateTime

P5875

285694518

http://www.w3.org/2001/XMLSchema#string

P698

27747761

http://www.w3.org/2001/XMLSchema#string

P932

4883259

http://www.w3.org/2001/XMLSchema#string

Current Practice Patterns and Educational Needs of Rheumatologists Who Manage Patients with Rheumatoid Arthritis.

about

P2860

P2860

Current Practice Patterns and Educational Needs of Rheumatologists Who Manage Patients with Rheumatoid Arthritis.

description

name

type

label

prefLabel

P1433

P1476

P2093

P2860

P2888

P304

P31

P356

P433

P478

P50

P577

P5875

P698

P932

P356

P1433

P1476

P2093

P2860

P2888

P304

P31

P356

P433

P478

P50

P577

P5875

P698

P932